ONTRAK INC (OTRK)

US6833733024 - Common Stock

0.293  -0.04 (-12.01%)

After market: 0.2919 0 (-0.38%)

Fundamental Rating

3

Overall OTRK gets a fundamental rating of 3 out of 10. We evaluated OTRK against 117 industry peers in the Health Care Providers & Services industry. While OTRK seems to be doing ok healthwise, there are quite some concerns on its profitability. OTRK is valied quite expensively at the moment, while it does show a decent growth rate.



1

1. Profitability

1.1 Basic Checks

In the past year OTRK has reported negative net income.
OTRK had a negative operating cash flow in the past year.
OTRK had negative earnings in each of the past 5 years.
OTRK had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

Looking at the Return On Assets, with a value of -185.79%, OTRK is doing worse than 94.83% of the companies in the same industry.
OTRK has a Return On Equity of -258.36%. This is amonst the worse of the industry: OTRK underperforms 81.03% of its industry peers.
Industry RankSector Rank
ROA -185.79%
ROE -258.36%
ROIC N/A
ROA(3y)-156.54%
ROA(5y)-118.81%
ROE(3y)-473.8%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

OTRK has a better Gross Margin (69.07%) than 90.52% of its industry peers.
OTRK's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for OTRK so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 69.07%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y13.4%
GM growth 5Y20.89%

5

2. Health

2.1 Basic Checks

OTRK does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, OTRK has more shares outstanding
The number of shares outstanding for OTRK has been increased compared to 5 years ago.
The debt/assets ratio for OTRK has been reduced compared to a year ago.

2.2 Solvency

OTRK has an Altman-Z score of -34.59. This is a bad value and indicates that OTRK is not financially healthy and even has some risk of bankruptcy.
OTRK has a worse Altman-Z score (-34.59) than 92.24% of its industry peers.
OTRK has a Debt/Equity ratio of 0.10. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of OTRK (0.10) is better than 76.72% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF N/A
Altman-Z -34.59
ROIC/WACCN/A
WACC5.95%

2.3 Liquidity

A Current Ratio of 3.24 indicates that OTRK has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 3.24, OTRK belongs to the top of the industry, outperforming 87.93% of the companies in the same industry.
OTRK has a Quick Ratio of 3.24. This indicates that OTRK is financially healthy and has no problem in meeting its short term obligations.
OTRK's Quick ratio of 3.24 is amongst the best of the industry. OTRK outperforms 87.93% of its industry peers.
Industry RankSector Rank
Current Ratio 3.24
Quick Ratio 3.24

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 61.72% over the past year.
Looking at the last year, OTRK shows a very negative growth in Revenue. The Revenue has decreased by -12.17% in the last year.
Measured over the past years, OTRK shows a decrease in Revenue. The Revenue has been decreasing by -3.44% on average per year.
EPS 1Y (TTM)61.72%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q19.44%
Revenue 1Y (TTM)-12.17%
Revenue growth 3Y-46.42%
Revenue growth 5Y-3.44%
Revenue growth Q2Q41%

3.2 Future

The Earnings Per Share is expected to grow by 15.47% on average over the next years. This is quite good.
The Revenue is expected to grow by 45.13% on average over the next years. This is a very strong growth
EPS Next Y91.05%
EPS Next 2Y40.11%
EPS Next 3Y25.83%
EPS Next 5Y15.47%
Revenue Next Year41.74%
Revenue Next 2Y50.35%
Revenue Next 3Y47.43%
Revenue Next 5Y45.13%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

1

4. Valuation

4.1 Price/Earnings Ratio

OTRK reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year OTRK is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as OTRK's earnings are expected to grow with 25.83% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y40.11%
EPS Next 3Y25.83%

0

5. Dividend

5.1 Amount

No dividends for OTRK!.
Industry RankSector Rank
Dividend Yield N/A

ONTRAK INC

NASDAQ:OTRK (4/26/2024, 7:08:27 PM)

After market: 0.2919 0 (-0.38%)

0.293

-0.04 (-12.01%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap8.08M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -185.79%
ROE -258.36%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 69.07%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.64
Health
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 3.24
Quick Ratio 3.24
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)61.72%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y91.05%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-12.17%
Revenue growth 3Y-46.42%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y